Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashley Vo

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Kidney International|November 4, 2022
A Banff-based histologic chronicity index is associated with graft loss in patients with a kidney transplant and antibody-mediated rejectionMark Haas, James Mirocha, Edmund Huang, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 14, 2011
Infectious complications in kidney-transplant recipients desensitized with rituximab and intravenous immunoglobulinJoseph Kahwaji, Aditi Sinha, Mieko Toyoda, et al.
Transplantation Direct|November 2, 2020
Donor-derived Cell-free DNA Combined With Histology Improves Prediction of Estimated Glomerular Filtration Rate Over Time in Kidney Transplant Recipients Compared With Histology AloneEdmund Huang, Matthew Gillespie, Noriko Ammerman, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 18, 2019
Three-Year Outcomes of a Randomized, Double-Blind, Placebo-Controlled Study Assessing Safety and Efficacy of C1 Esterase Inhibitor for Prevention of Delayed Graft Function in Deceased Donor Kidney Transplant RecipientsEdmund Huang, Ashley Vo, Jua Choi, et al.
Transplantation|September 25, 2018
Novel Therapeutic Approaches to Allosensitization and Antibody-mediated RejectionStanley C Jordan, Noriko Ammerman, Jua Choi, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 25, 2022
Viral-specific cytotoxic T-cell responses in HLA-sensitized kidney transplant patients maintained on everolimus and low-dose tacrolimusShili Ge, Maggie Chu, Jacqueline Tang, et al.
Transplantation|April 2, 2014
Polyomavirus BK viremia in kidney transplant recipients after desensitization with IVIG and rituximabDebora Barbosa, Joseph Kahwaji, Dechu Puliyanda, et al.
Transplantation|July 26, 2005
Co-infection of polyomavirus-BK and cytomegalovirus in renal transplant recipientsMieko Toyoda, Dechu P Puliyanda, Nurmamet Amet, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 16, 2020
The role of novel therapeutic approaches for prevention of allosensitization and antibody-mediated rejectionStanley C Jordan, Noriko Ammerman, Jua Choi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 12, 2018
A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipientsStanley C Jordan, Jua Choi, Olivier Aubert, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Kidney International|November 4, 2022
A Banff-based histologic chronicity index is associated with graft loss in patients with a kidney transplant and antibody-mediated rejectionMark Haas, James Mirocha, Edmund Huang, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 14, 2011
Infectious complications in kidney-transplant recipients desensitized with rituximab and intravenous immunoglobulinJoseph Kahwaji, Aditi Sinha, Mieko Toyoda, et al.
Transplantation Direct|November 2, 2020
Donor-derived Cell-free DNA Combined With Histology Improves Prediction of Estimated Glomerular Filtration Rate Over Time in Kidney Transplant Recipients Compared With Histology AloneEdmund Huang, Matthew Gillespie, Noriko Ammerman, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 18, 2019
Three-Year Outcomes of a Randomized, Double-Blind, Placebo-Controlled Study Assessing Safety and Efficacy of C1 Esterase Inhibitor for Prevention of Delayed Graft Function in Deceased Donor Kidney Transplant RecipientsEdmund Huang, Ashley Vo, Jua Choi, et al.
Transplantation|September 25, 2018
Novel Therapeutic Approaches to Allosensitization and Antibody-mediated RejectionStanley C Jordan, Noriko Ammerman, Jua Choi, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 25, 2022
Viral-specific cytotoxic T-cell responses in HLA-sensitized kidney transplant patients maintained on everolimus and low-dose tacrolimusShili Ge, Maggie Chu, Jacqueline Tang, et al.
Transplantation|April 2, 2014
Polyomavirus BK viremia in kidney transplant recipients after desensitization with IVIG and rituximabDebora Barbosa, Joseph Kahwaji, Dechu Puliyanda, et al.
Transplantation|July 26, 2005
Co-infection of polyomavirus-BK and cytomegalovirus in renal transplant recipientsMieko Toyoda, Dechu P Puliyanda, Nurmamet Amet, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 16, 2020
The role of novel therapeutic approaches for prevention of allosensitization and antibody-mediated rejectionStanley C Jordan, Noriko Ammerman, Jua Choi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 12, 2018
A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipientsStanley C Jordan, Jua Choi, Olivier Aubert, et al.
Pageof 7